Sumitomo Mitsui Trust Group
MDT icon

Sumitomo Mitsui Trust Group’s Medtronic MDT Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$264M Sell
3,043,427
-138,554
-4% -$13.3M 0.17% 112
2025
Q4 		$306M Sell
3,181,981
-29,238
-0.9% -$2.84M 0.18% 111
2025
Q3 		$306M Sell
3,211,219
-7,787
-0.2% -$716K 0.18% 112
2025
Q2 		$281M Buy
3,219,006
+167,709
+5% +$14.2M 0.17% 117
2025
Q1 		$274M Buy
3,051,297
+12,951
+0.4% +$1.16M 0.19% 110
2024
Q4 		$243M Buy
3,038,346
+7,186
+0.2% +$622K 0.16% 123
2024
Q3 		$273M Sell
3,031,160
-50,038
-2% -$4.21M 0.19% 108
2024
Q2 		$243M Sell
3,081,198
-126,176
-4% -$10.3M 0.18% 119
2024
Q1 		$280M Buy
3,207,374
+8,118
+0.3% +$693K 0.19% 109
2023
Q4 		$264M Sell
3,199,256
-24,053
-0.7% -$1.83M 0.19% 116
2023
Q3 		$253M Sell
3,223,309
-54,026
-2% -$4.52M 0.21% 103
2023
Q2 		$289M Sell
3,277,335
-753,207
-19% -$64.8M 0.22% 93
2023
Q1 		$325M Buy
4,030,542
+263,198
+7% +$21.5M 0.24% 91
2022
Q4 		$293M Sell
3,767,344
-48,968
-1% -$3.97M 0.23% 101
2022
Q3 		$308M Sell
3,816,312
-709,006
-16% -$63.7M 0.25% 84
2022
Q2 		$406M Buy
4,525,318
+185,302
+4% +$18.8M 0.31% 63
2022
Q1 		$482M Buy
+4,340,016
New +$459M 0.32% 66
2015
Q1 		– Sell
-2,295,256
Closed -$168M – 898
2014
Q4 		$168M Sell
2,295,256
-74,952
-3% -$5.21M 0.33% 72
2014
Q3 		$147M Buy
2,370,208
+4,529
+0.2% +$288K 0.29% 78
2014
Q2 		$151M Sell
2,365,679
-104,756
-4% -$6.36M 0.31% 78
2014
Q1 		$152M Sell
2,470,435
-87,959
-3% -$5.12M 0.32% 73
2013
Q4 		$147M Sell
2,558,394
-134,945
-5% -$7.65M 0.3% 76
2013
Q3 		$143M Sell
2,693,339
-13,347
-0.5% -$718K 0.31% 75
2013
Q2 		$139M Buy
+2,706,686
New +$134M 0.31% 70

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group's MDT Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its Medtronic (MDT) stake by 4.4% in Q1 2026, selling an estimated $13.3M and leaving 3,043,427 shares worth $264M. The position accounts for 0.17% of the portfolio, ranked #112.

Sumitomo Mitsui Trust Group first reported a position in MDT in Q2 2013 and has held it in 24 quarters since. The position peaked at $482M in Q1 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 3,043,427 shares of Medtronic worth $264M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 138,554 Medtronic shares in Q1 2026, an estimated $13.3M.
  • Medtronic made up 0.17% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #112 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Medtronic in Q2 2013 and has held it in 24 quarters since.
  • Sumitomo Mitsui Trust Group's Medtronic position peaked at $482M in Q1 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.